Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP600542.RAHl-NTOtaPFxc2-bax653C9hQ3usDF-r1z_N9jjoIaX0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP600542.RAHl-NTOtaPFxc2-bax653C9hQ3usDF-r1z_N9jjoIaX0130_assertion type Assertion NP600542.RAHl-NTOtaPFxc2-bax653C9hQ3usDF-r1z_N9jjoIaX0130_head.
- NP600542.RAHl-NTOtaPFxc2-bax653C9hQ3usDF-r1z_N9jjoIaX0130_assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600542.RAHl-NTOtaPFxc2-bax653C9hQ3usDF-r1z_N9jjoIaX0130_provenance.
- NP600542.RAHl-NTOtaPFxc2-bax653C9hQ3usDF-r1z_N9jjoIaX0130_assertion evidence source_evidence_literature NP600542.RAHl-NTOtaPFxc2-bax653C9hQ3usDF-r1z_N9jjoIaX0130_provenance.
- NP600542.RAHl-NTOtaPFxc2-bax653C9hQ3usDF-r1z_N9jjoIaX0130_assertion SIO_000772 16517839 NP600542.RAHl-NTOtaPFxc2-bax653C9hQ3usDF-r1z_N9jjoIaX0130_provenance.
- NP600542.RAHl-NTOtaPFxc2-bax653C9hQ3usDF-r1z_N9jjoIaX0130_assertion wasDerivedFrom befree-20140225 NP600542.RAHl-NTOtaPFxc2-bax653C9hQ3usDF-r1z_N9jjoIaX0130_provenance.
- NP600542.RAHl-NTOtaPFxc2-bax653C9hQ3usDF-r1z_N9jjoIaX0130_assertion wasGeneratedBy ECO_0000203 NP600542.RAHl-NTOtaPFxc2-bax653C9hQ3usDF-r1z_N9jjoIaX0130_provenance.